Authored By: Sarah
19 Jun 2024

 Bilirubin Blood Test Market to grow by USD 552.66 million between 2024-2028

According to a research report “ Bilirubin Blood Test Market” by End-user (Infants, Adults) Product Type (Instruments, Consumables) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 552.66 million at a CAGR of over 6.24% during the forecast period. The global bilirubin blood test market is poised for significant growth due to the increasing prevalence of jaundice, a condition characterized by the accumulation of bilirubin in the blood. Bilirubin is a yellowish substance generated during the breakdown of hemoglobin in red blood cells. Neonatal jaundice, a common cause of morbidity and mortality in newborns, accounts for a substantial proportion of jaundice cases, affecting up to 80% of preterm and 60% of term infants. The high demand for diagnosing and managing neonatal jaundice will consequently fuel market expansion throughout the forecast period..

Browse market data tables, figures, and in-depth TOC on “Bilirubin Blood Test Market” by End-user (Infants, Adults) Product Type (Instruments, Consumables) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By End-user, the Infants segment is projected to dominate the market size in 2024.

In the bilirubin blood test market, the instruments segment is a significant contributor, comprising advanced devices like spectrophotometers and analyzers. These tools are indispensable in diagnostic laboratories and healthcare settings for evaluating liver function and diagnosing conditions such as jaundice. Market expansion in this segment is fueled by technological innovations, automation trends, and the escalating need for precise and efficient diagnostic solutions in the clinical sector. The instruments segment is witnessing substantial growth due to factors such as technological advancements, the increasing prevalence of liver disorders, and the global emphasis on preventive healthcare screening programs.

By Product Type, Instruments  segment is expected to hold the largest market size for the year 2024.

In the global bilirubin blood test market, the infant segment holds a significant market share. Factors such as the increasing incidence of neonatal jaundice, new product introductions, and regulatory initiatives to raise awareness about neonatal jaundice are driving segment growth. The primary growth catalyst is the high prevalence of neonatal jaundice, particularly among preterm infants, with approximately 80% of premature babies affected, according to the Centers for Disease Control and Prevention (CDC).

North America is forecasted to hold the largest market size by region in 2024.

In North America, the bilirubin blood test market is projected to expand at a steady pace due to technological innovations in testing solutions, frequent product launches, and the rising prevalence of chronic liver diseases and neonatal jaundice. The significant incidence of liver disorders among patients, characterized by impaired bilirubin metabolism, fuels market growth.

The Bilirubin Blood Test Market t growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Advanced Instruments LLC
  • ALLMEDTECH
  • AMETEK Inc.
  • Anamol Laboratories Pvt. Ltd.
  • BIOGENIX Inc. Pvt. Ltd.
  • DiaSys Diagnostic Systems GmbH
  • Dragerwerk AG and Co. KGaA
  • ELITechGroup SAS
  • F. Hoffmann La Roche Ltd.
  • GINEVRI Srl
  • Jaiprakash Associates Ltd.
  • Koninklijke Philips N.V.
  • Mega Lab SA
  • Merck KGaA
  • Micro Lab Instruments
  • Randox Laboratories Ltd.
  • Siemens AG
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Bilirubin Blood Test Market encompasses diagnostic techniques used to identify various liver conditions and associated complications, such as hemolytic anemias, including Gilbert's syndrome. These tests play a crucial role in detecting liver diseases, including hepatitis and other illnesses affecting the organ's functionality. Bilirubin blood tests measure the levels of total and indirect bilirubin in a patient's bloodstream. Transcutaneous and bench-top diagnostic devices are increasingly popular in hospitals and clinical settings due to their convenience and ease of use. These tests help diagnose conditions like jaundice, dark urine, and yellowing of the eyes and skin, which can be indicative of liver dysfunction or gallbladder issues. Infants, too, undergo bilirubin blood tests to monitor for potential liver problems or heme disorders like anemia. The Coronavirus pandemic has further emphasized the importance of these tests in ensuring early detection and treatment of various liver conditions.

Market Research Overview

The Bilirubin Blood Test market encompasses various diagnostic techniques used to identify liver diseases and anemia conditions, such as Hemolytic anemia and Gilbert's syndrome. These tests include the Indirect Bilirubin Test, Direct Bilirubin Test, and Total Bilirubin Test. Hospitals, academic institutions, research laboratories, diagnostics centers, and medical agencies utilize these tests to diagnose a range of liver conditions, including hepatitis and respiratory problems related to coronavirus. Bilirubin meters, analyzers, and instruments are essential consumables in this market. Unconjugated Bilirubin Test is another diagnostic technique used to detect liver diseases in infants, who may exhibit symptoms like jaundice, dark urine, and yellowing of the eyes and skin. Portable testing kits and transcutaneous devices offer convenience for patients, enabling tests to be conducted outside of traditional hospital settings. Diagnostic technologies for Bilirubin Blood Tests have evolved, with bench-top and portable analyzers offering quick and accurate results. These tests play a crucial role in identifying liver diseases, anemia, and other conditions, ensuring timely and effective treatment for patients.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio